Literature DB >> 22069171

Histopathology of gastrointestinal stromal tumor.

Markku Miettinen1, Jerzy Lasota.   

Abstract

Gastrointestinal stromal tumor (GIST), generally driven by oncogenic KIT or PDGFRA mutations, is the most common mesenchymal tumor of the gastrointestinal (GI) tract. GIST is most common in the stomach (60%) and small intestine (30%), but can occur anywhere in the GI-tract and the intra-abdominal soft tissues. GIST can show spindle cell or epithelioid morphology, and mitotic count and tumor size are most important prognostic parameters. GISTs in NF1 patients and children are distinctive clinicopathologic groups. Immunohistochemical testing for KIT and sometimes for DOG1/Ano 1 is essential in confirming the diagnosis.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069171      PMCID: PMC7384443          DOI: 10.1002/jso.21945

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  64 in total

1.  Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.

Authors:  Abbas Agaimy; Peter H Wünsch; Ferdinand Hofstaedter; Hagen Blaszyk; Petra Rümmele; Andreas Gaumann; Wolfgang Dietmaier; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

2.  Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

Authors:  Markku Miettinen; John F Fetsch; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

3.  Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature.

Authors:  Markku Miettinen; Jerzy Lasota; Leslie H Sobin
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

4.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

5.  Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad.

Authors:  J Aidan Carney; Constantine A Stratakis
Journal:  Am J Med Genet       Date:  2002-03-01

6.  A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.

Authors:  Brian P Rubin; Cristina R Antonescu; James P Scott-Browne; Melissa L Comstock; Yansong Gu; Munir R Tanas; Carol B Ware; Jessica Woodell
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

7.  Small intestinal stromal tumors with skeinoid fibers. Clinicopathological, immunohistochemical, and ultrastructural investigations.

Authors:  K W Min
Journal:  Am J Surg Pathol       Date:  1992-02       Impact factor: 6.394

8.  Microscopic gastrointestinal stromal tumors in esophageal and intestinal surgical resection specimens: a clinicopathologic, immunohistochemical, and molecular study of 19 lesions.

Authors:  Abbas Agaimy; Peter H Wünsch; Stephan Dirnhofer; Michel P Bihl; Luigi M Terracciano; Luigi Tornillo
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

9.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

10.  PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor.

Authors:  Agnès Chompret; Caroline Kannengiesser; Michel Barrois; Philippe Terrier; Philippe Dahan; Thomas Tursz; Gilbert M Lenoir; Brigitte Bressac-De Paillerets
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  73 in total

Review 1.  GISTogram: a graphic presentation of the growing GIST complexity.

Authors:  Riccardo Ricci; Angelo Paolo Dei Tos; Guido Rindi
Journal:  Virchows Arch       Date:  2013-08-23       Impact factor: 4.064

Review 2.  The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.

Authors:  Tong Dai; Elizabeta Popa; Manish A Shah
Journal:  Curr Treat Options Oncol       Date:  2014-09

3.  [Non-PSA-expressing, solid, and growing mass of the prostate].

Authors:  F Christoph; S Ebrahimsade; M Schostak
Journal:  Urologe A       Date:  2017-10       Impact factor: 0.639

4.  Surgery for gastrointestinal stromal tumors (GISTs) of the stomach and small bowel: short- and long-term outcomes over three decades.

Authors:  Oddvar M Sandvik; Kjetil Søreide; Einar Gudlaugsson; Jon Arne Søreide
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

5.  Understanding the critical role for surgery in the management of wild-type gastrointestinal stromal tumor (GIST).

Authors:  Bradford J Kim; Joshua K Kays; Leonidas G Koniaris; Nakul P Valsangkar
Journal:  Transl Gastroenterol Hepatol       Date:  2017-11-15

6.  Clinical and pathological characteristics of gastrointestinal stromal tumor (GIST) metastatic to bone.

Authors:  Kemal Kosemehmetoglu; Gulsah Kaygusuz; Karen Fritchie; Ovgu Aydin; Ozlem Yapicier; Oznur Coskun; Ersin Karatayli; Senay Boyacigil; Gulnur Guler; Sergulen Dervisoglu; Isinsu Kuzu
Journal:  Virchows Arch       Date:  2017-05-09       Impact factor: 4.064

Review 7.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

8.  No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.

Authors:  Jerzy Lasota; Liqiang Xi; Tiffany Coates; RaShonda Dennis; Moses O Evbuomwan; Zeng-Feng Wang; Mark Raffeld; Markku Miettinen
Journal:  Mod Pathol       Date:  2013-05-24       Impact factor: 7.842

9.  Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors.

Authors:  Eckhard Klieser; Maximilian Pichelstorfer; Denis Weyland; Ralf Kemmerling; Stefan Swierczynski; Adam Dinnewitzer; Tarkan Jäger; Tobias Kiesslich; Daniel Neureiter; Romana Illig
Journal:  Mol Clin Oncol       Date:  2016-03-11

10.  Management of early asymptomatic gastrointestinal stromal tumors of the stomach.

Authors:  Hans Scherübl; Siegbert Faiss; Wolfram-Trudo Knoefel; Eva Wardelmann
Journal:  World J Gastrointest Endosc       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.